Further in vitro studies showed that tumor necrosis factor (TNF)-α (a vitamin D3 antagonist) mediates the suppression of SRC3, leading to alveolar macrophage cathelicidin deficiency in severe sarcoidosis. This evidence concerns the gene TNF and sarcoidosis.